Amy Moore
Acute Care · Phoenix, AZNPI 1831731769
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $4,000 of the $6,070 with a category attached, or 65.9%. Pulmonx Corporation accounts for 76.1% of it on its own, with 19 other manufacturers making up the rest. 2025 is the largest year on record at $4,878, more than ten times the $205 reported in 2021. Among acute care clinicians in AZ with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 45 payments — averaging $134.88 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Pulmonx Corporation$5K
- Astellas Pharma US Inc$368
- Actelion Pharmaceuticals US, Inc.$174
- Intuitive Surgical$159
- United Therapeutics Corporation$153
- Pharming Healthcare, Inc.$107
- plus $489 from 14 others
What the payments were for
- Consulting fees$4,00066%
- Food & beverage$1,69828%
- Education$3726%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Pulmonx Corporation | 7 | $4,621 |
| Astellas Pharma US Inc | 6 | $368 |
| Actelion Pharmaceuticals US, Inc. | 5 | $174 |
| Intuitive Surgical | 2 | $159 |
| United Therapeutics Corporation | 2 | $153 |
| Pharming Healthcare, Inc. | 1 | $107 |
| Mylan Specialty L.p. | 2 | $68 |
| AstraZeneca | 4 | $60 |
| Insmed, Inc. | 2 | $55 |
| Medtronic | 1 | $46 |
| Electromed, Inc. | 3 | $38 |
| Baxter Healthcare | 2 | $30 |
| Verona Pharma, Inc. | 1 | $30 |
| AbbVie | 1 | $29 |
| Boehringer Ingelheim | 1 | $29 |
| Merck | 1 | $27 |
| Vifor Pharma, Inc. | 1 | $24 |
| Genentech USA, Inc. | 1 | $20 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $17 |
| Sanofi | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ZEPHYR ENDOBRONCHIAL VALVE$4,621
- CHARTIS CATHETER$2,621
- ZEPHYR DELIVERY CATHETER$2,621
- PULMONX CHARTIS TABLET CONSOLE$2,621
How this compares
$6,070 in reported general payments places this provider in the 90th percentile of 482 acute care providers in Arizona.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 21 | $17,661 |
| Azithromycin | 27 | $52 |
Paid to pharmacies, not to this prescriber.
Other acute care in Phoenix
- Kim KrmpoticPhoenix$79K
- Laura Cook-GongoraPhoenix$32K
- Cathy PaynePhoenix$26K
- Chandra SorrellePhoenix$16K
- Nicole RauscherPhoenix$12K
- Brooke GambinoPhoenix$11K
- Kelly WesselhoffPhoenix$9K
- Jenna GonzalesPhoenix$8K
- Kristen HudsonPhoenix$8K
- Tammy TyreePhoenix$8K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.